Skip to main content

REVIEW article

Front. Cell. Infect. Microbiol.
Sec. Molecular Bacterial Pathogenesis
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1374238

The Footprint of Gut Microbiota in Gallbladder Cancer: A Mechanistic Review Provisionally Accepted

  • 1Nanchang University, China
  • 2Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Gallbladder cancer (GBC) is the most common malignant tumor of the biliary system with the worst prognosis. Even after radical surgery, the majority of patients with GBC have difficulty achieving a clinical cure. The risk of tumor recurrence remains more than 65%, and the overall 5-year survival rate is less than 5%. The gut microbiota refers to a variety of microorganisms living in the human intestine, including bacteria, viruses and fungi, which profoundly affect the host state of general health, disease and even cancer. Over the past few decades, substantial evidence has supported that gut microbiota plays a critical role in promoting the progression of GBC. In this review, we summarize the functions, molecular mechanisms and recent advances of the intestinal microbiota in GBC. We focus on the driving role of bacteria in pivotal pathways, such as virulence factors, metabolites derived from intestinal bacteria, chronic inflammatory responses and ecological niche remodeling. Additionally, we emphasize the high level of correlation between viruses and fungi, especially EBV and Candida spp., with GBC. In general, this review not only provides a solid theoretical basis for the close relationship between gut microbiota and GBC but also highlights more potential research directions for further research in the future.

Keywords: Gut Microbiota, gallbladder cancer, Virulence Factors, Metabolites, chronic inflammation, ecological niche

Received: 21 Jan 2024; Accepted: 22 Apr 2024.

Copyright: © 2024 Liu, Li, Chen, Li, Geng, Liu and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Mx. Yajun Geng, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200000, China
Mx. Yingbin Liu, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200000, China
Mx. Wenguang Wu, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200000, China